A-LIGN Vulnerability Assessment Service vs Armis Centrix™ for VIPR: 2026 Comparison

A-LIGN Vulnerability Assessment Service

Mid-market and enterprise teams managing hybrid infrastructure will value A-LIGN Vulnerability Assessment Service for its ability to scan both on-premises and cloud environments in a single workflow without forcing tool consolidation. The service covers authenticated and unauthenticated scans across network and application layers with scheduled continuous monitoring, hitting both ID.RA and DE.CM in NIST CSF 2.0. Skip this if you need a platform that bundles remediation orchestration or threat intelligence; A-LIGN is assessment-focused, leaving remediation execution to your existing ticketing and patching systems.

Armis Centrix™ for VIPR

Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output.